Eisai Co., Ltd.

General ticker "ESALF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $8.3B (TTM average)

Eisai Co., Ltd. follows the US Stock Market performance with the rate: 14.2%.

Estimated limits based on current volatility of 2.4%: low 29.65$, high 31.11$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-09-30, amount 0.54$ (Y1.80%)
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

  • 2025-03-31 to 2026-03-31 estimated range: [19.41$, 37.24$]
  • 2026-03-31 to 2027-03-31 estimated range: [20.33$, 37.84$]

Financial Metrics affecting the ESALF estimates:

  • Positive: with PPE of 0.4 at the end of fiscal year the price was neutral
  • Positive: -3.60 < Operating profit margin, % of 6.89
  • Negative: negative Industry operating cash flow (median)
  • Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.24
  • Negative: Inventory ratio change, % of 2.42 > 0.84
  • Positive: 41.86 < Shareholder equity ratio, % of 60.68 <= 63.39

Similar symbols

Short-term ESALF quotes

Long-term ESALF plot with estimates

Financial data

YTD 2023-03-31 2024-03-31 2025-03-31
Operating Revenue ¥744,402.00MM ¥741,751.00MM ¥789,400.00MM
Operating Expenses ¥704,362.00MM ¥688,343.00MM ¥735,022.00MM
Operating Income ¥40,040.00MM ¥53,408.00MM ¥54,378.00MM
Non-Operating Income ¥4,972.00MM ¥8,415.00MM ¥6,687.00MM
Interest Expense ¥2,266.00MM ¥2,388.00MM ¥3,519.00MM
R&D Expense ¥156,691.00MM ¥169,021.00MM ¥171,633.00MM
Income(Loss) ¥45,012.00MM ¥61,823.00MM ¥61,065.00MM
Taxes ¥-11,824.00MM ¥18,040.00MM ¥13,007.00MM
Profit(Loss)* ¥55,432.00MM ¥42,407.00MM ¥46,433.00MM
Stockholders Equity ¥799,959.00MM ¥875,614.00MM ¥841,417.00MM
Inventory ¥140,417.00MM ¥174,651.00MM ¥215,905.00MM
Assets ¥1,263,350.00MM ¥1,393,799.00MM ¥1,386,547.00MM
Operating Cash Flow ¥-1,772.00MM ¥55,993.00MM ¥30,117.00MM
Capital expenditure ¥34,559.00MM ¥24,823.00MM ¥22,969.00MM
Investing Cash Flow ¥-22,723.00MM ¥-25,321.00MM ¥-10,097.00MM
Financing Cash Flow ¥-24,522.00MM ¥-22,720.00MM ¥-57,809.00MM
Earnings Per Share** ¥193.31 ¥147.86 ¥163.76

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.